Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : ONCY save search
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 1.85%
H: 0.0%
C: 0.0%
biotech fda breast cancer for meeting trial submission
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Published: 2024-03-07 (Crawled : 21:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 2.88%
H: 4.67%
C: -1.87%
biotech year financial results
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
Published: 2024-03-05 (Crawled : 12:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 6.52%
H: 6.12%
C: 5.1%
biotech cancer pancreatic
Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors
Published: 2024-01-09 (Crawled : 14:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -0.74%
H: 0.74%
C: -8.15%
biotech
Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS
Published: 2023-12-07 (Crawled : 18:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 2.92%
H: 0.0%
C: -0.71%
biotech positive sabcs
Oncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational Highlights
Published: 2023-11-03 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.0%
H: 0.56%
C: -3.91%
biotech financial results
Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC
Published: 2023-11-03 (Crawled : 16:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.0%
H: 0.56%
C: -3.91%
biotech positive
Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMO
Published: 2023-10-23 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.65%
H: 9.94%
C: 8.33%
positive cancer pancreatic study
Oncolytics Achieves Success Criteria for Efficacy in the Third-Line Colorectal Cancer Cohort of the GOBLET Study
Published: 2023-10-23 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.65%
H: 9.94%
C: 8.33%
success cancer study
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights
Published: 2023-10-20 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.85%
H: 3.14%
C: -2.52%
biotech conference financial results
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
Published: 2023-10-20 (Crawled : 14:30) - prnewswire.com
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.85%
H: 3.14%
C: -2.52%
MYGN F | $18.515 0.03% 0.03% 490K
|
Health Technology
|
| O: 0.41%
H: 3.13%
C: 2.38%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 0.02%
H: 0.94%
C: -0.3%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.46%
H: 0.48%
C: -1.06%
companies biotech cancer pancreatic treatment research
Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study at ESMO 2023
Published: 2023-10-16 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 1.61%
H: 1.59%
C: -3.17%
biotech study
New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review
Published: 2023-10-13 (Crawled : 13:00) - prnewswire.com
PYXS | $4.155 -8.28% -9.03% 670K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 2.56%
C: 2.56%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.63%
H: 4.97%
C: 2.76%
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: 0.47%
H: 1.7%
C: -0.38%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.59%
H: 0.62%
C: -0.56%
fda year review cancer pancreatic
THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS
Published: 2023-09-26 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.0%
H: 5.63%
C: 4.69%
biotech award cancer pancreatic network
Oncolytics Biotech® Announces Fireside Chat at the Cantor Global Healthcare Conference
Published: 2023-09-19 (Crawled : 14:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.47%
H: 4.98%
C: 3.98%
biotech conference global
Pancreatic Cancer Battle Boosted by $200M VC Firm
Published: 2023-09-19 (Crawled : 17:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.47%
H: 4.98%
C: 3.98%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -0.13%
H: 2.0%
C: 1.83%
MACK 4 | $14.72 0.27% 0.27% 76K
|
Health Technology
|
| O: -0.41%
H: 0.9%
C: 0.74%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.03%
H: 2.18%
C: 1.8%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.01%
H: 1.99%
C: 1.28%
cancer pancreatic
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
Published: 2023-09-13 (Crawled : 14:30) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -2.2%
H: 0.9%
C: -1.8%
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.26%
H: 0.69%
C: 0.4%
FULC | $6.86 -2.83% -2.92% 560K
|
Health Technology
|
| O: -0.19%
H: 0.0%
C: -8.83%
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: -1.12%
H: 3.87%
C: -1.94%
RNA | $22.74 -1.3% -1.32% 1M
|
Health Technology
|
| O: 1.25%
H: 3.01%
C: -2.6%
fda biotech momentum
Oncolytics Biotech® Reports Second Quarter 2023 Financial Results and Operational Highlights
Published: 2023-08-14 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -3.67%
H: 0.95%
C: -2.38%
biotech financial results
Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 43rd Annual Growth Conference
Published: 2023-08-04 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -4.93%
H: 0.0%
C: 0.0%
biotech conference growth
Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights
Published: 2023-08-04 (Crawled : 11:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -4.93%
H: 0.0%
C: 0.0%
biotech conference financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.